Sonendo, Inc. develops, manufactures, and sells devices for root canal therapy in the United States and Canada. It offers GentleWave, a device to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of ethylenediaminetetraacetic acid used to help debride and disinfect the root canal system. In addition, it provides The Digital Office, a practice management software. The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011. Sonendo, Inc. was incorporated in 2006 and is based in Laguna Hills, California.
IPO Year: 2021
Exchange: NYSE
Website: sonendo.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/12/2024 | Buy → Hold | Stifel | |
| 1/31/2022 | $6.90 | Equal-Weight | Morgan Stanley |
| 11/23/2021 | $16.00 | Buy | Stifel |
| 11/23/2021 | $15.00 | Buy | B of A Securities |
| 11/23/2021 | $30.00 | Buy | Goldman Sachs |
| 11/23/2021 | $17.00 | Overweight | Piper Sandler |
Stifel downgraded Sonendo from Buy to Hold
Morgan Stanley initiated coverage of Sonendo with a rating of Equal-Weight and set a new price target of $6.90
Stifel initiated coverage of Sonendo with a rating of Buy and set a new price target of $16.00
B of A Securities initiated coverage of Sonendo with a rating of Buy and set a new price target of $15.00
Goldman Sachs initiated coverage of Sonendo with a rating of Buy and set a new price target of $30.00
Piper Sandler initiated coverage of Sonendo with a rating of Overweight and set a new price target of $17.00
4 - Sonendo, Inc. (0001407973) (Issuer)
4 - Sonendo, Inc. (0001407973) (Issuer)
4 - Sonendo, Inc. (0001407973) (Issuer)
4 - Sonendo, Inc. (0001407973) (Issuer)
4 - Sonendo, Inc. (0001407973) (Issuer)
4 - Sonendo, Inc. (0001407973) (Issuer)
4 - Sonendo, Inc. (0001407973) (Issuer)
4 - Sonendo, Inc. (0001407973) (Issuer)
4 - Sonendo, Inc. (0001407973) (Issuer)
4 - Sonendo, Inc. (0001407973) (Issuer)
SC 13G/A - Sonendo, Inc. (0001407973) (Subject)
SC 13G - Sonendo, Inc. (0001407973) (Subject)
SC 13G/A - Sonendo, Inc. (0001407973) (Subject)
SC 13G/A - Sonendo, Inc. (0001407973) (Subject)
SC 13G - Sonendo, Inc. (0001407973) (Subject)
SC 13G/A - Sonendo, Inc. (0001407973) (Subject)
SC 13G/A - Sonendo, Inc. (0001407973) (Subject)
SC 13G - Sonendo, Inc. (0001407973) (Subject)
SC 13G/A - Sonendo, Inc. (0001407973) (Subject)
SC 13G/A - Sonendo, Inc. (0001407973) (Subject)
D - Sonendo, Inc. (0001407973) (Filer)
10-K - Sonendo, Inc. (0001407973) (Filer)
EFFECT - Sonendo, Inc. (0001407973) (Filer)
EFFECT - Sonendo, Inc. (0001407973) (Filer)
S-8 POS - Sonendo, Inc. (0001407973) (Filer)
S-8 POS - Sonendo, Inc. (0001407973) (Filer)
S-8 POS - Sonendo, Inc. (0001407973) (Filer)
S-8 POS - Sonendo, Inc. (0001407973) (Filer)
S-8 POS - Sonendo, Inc. (0001407973) (Filer)
S-8 POS - Sonendo, Inc. (0001407973) (Filer)
Sonendo, Inc. (OTC:SONX) ("Sonendo" or the "Company"), a leading dental technology company and developer of the GentleWave® System, today announced a private placement of common stock, resulting in gross proceeds of $5.0 million (the "Private Placement"). New and existing investors, including certain directors and officers of the Company, participated in the financing. Sonendo intends to use the proceeds from the financing to expand commercial programs to drive revenue growth, continue executing ongoing business restructuring activities to further reduce operating expenses and accelerate the path to positive adjusted EBITDA and operating cash flow, to retain senior leadership and key emplo
Sonendo, Inc. (OTC:SONX) ("Sonendo" or the "Company"), a leading dental technology company and developer of the GentleWave® System, today reported financial results for the quarter and year ended December 31, 2024. Quarterly Highlights Generated $8.3 million total revenue for the fourth quarter 2024; Drove substantial 1,570 and 1,260 basis points of GAAP and adjusted (non-GAAP) gross margin expansion for the fourth quarter 2024 to 41.1% and 41.3%, respectively, as compared to the prior year quarter; Significantly reduced GAAP operating loss to $5.6 million and adjusted EBITDA (non-GAAP) loss to $4.7 million for the fourth quarter 2024, an improvement of 45.2% and 45.0%, respectively,
Sonendo, Inc. ("Sonendo" or the "Company") (OTCQX:SONX), a leading dental technology company and developer of the GentleWave® System, today reported financial results for the third quarter ended September 30, 2024. Recent Highlights Generated $8.0 million total revenue for the third quarter of 2024 and carried over a double-digit console backlog for the third straight quarter; Drove substantial increases in GAAP gross margin and adjusted gross margins (non-GAAP) to 41.2% and 42.6%, respectively, based primarily on lower manufacturing and console warranty costs; Significantly reduced GAAP operating loss to $7.5 million and adjusted EBITDA (non-GAAP) loss to $5.1 million, a 57% and
Sonendo, Inc. ("Sonendo") (OTCQX:SONX), a leading dental technology company and developer of the GentleWave® System, today announced that management will postpone the third quarter 2024 conference call that was previously scheduled for after the market close on Tuesday, November 12th, 2024. The Company still intends to file its audited financial results on November 12th, 2024, but has postponed, until further notice, the accompanying conference call. Management will provide commentary on events subsequent to the end of the quarter ending September 30th, 2024, at a later date. About Sonendo Sonendo is a commercial-stage medical technology Company focused on saving teeth from tooth deca
Sonendo, Inc. ("Sonendo") (OTCQX:SONX), a leading dental technology company and developer of the GentleWave® System, today announced that it will report financial results for the third quarter 2024 after the market close on Tuesday, November 12th, 2024. Management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results. Investors interested in listening to the conference call may do so by dialing (833) 470-1428 for domestic callers or (404) 975-4839 for international callers, using access code: 788725. Live audio of the webcast will be available at: https://investor.sonendo.com. An archived recording will be available on th
Sonendo, Inc. (OTCQX:SONX) ("Sonendo"), a leading dental technology company and developer of the GentleWave® System, today announced the launch of ProControl™ as the Company's latest advancement in endodontic care. The ProControl software update enables optimized cleaning of complex anatomy and increased procedure efficiency. ProControl allows endodontists to adjust procedure fluid concentration levels when using the CleanFlowTM procedure instrument, tailoring treatments to each patient's unique needs. This advancement expands the clinical flexibility for the GentleWave G4 System enabling optimal clinical outcomes and an improved patient experience through personalized treatment. "ProCont
Raises Full-Year 2024 Revenue Guidance Sonendo, Inc. ("Sonendo" or the "Company") (OTCQX:SONX), a leading dental technology company and developer of the GentleWave® System, today announced certain unaudited preliminary financial results for the three months ended September 30, 2024. Unaudited Preliminary Third Quarter 2024 Financial Results Total revenue is expected to range from $7.9 to $8.0 million Console revenue is expected to be approximately $1.8 million Procedural instrument revenue is expected to be approximately $5.1 million The Company once again carried over a double-digit console backlog for the third straight quarter Cash, cash equivalents and short-term investmen
Sonendo, Inc. (OTCQX:SONX) ("Sonendo" or "Company"), a leading dental technology company and developer of the GentleWave® System, today announced that the Company has entered into an Asset Purchase Agreement ("APA") with Biolase, Inc. and certain of its subsidiaries (the "Sellers") pursuant to which the Company agreed to acquire substantially all of the assets of the Sellers and their subsidiaries for a total purchase price of $14 million, plus the assumption of certain operating liabilities and the settlement value of certain ongoing patent litigation between Sonendo's subsidiary PIPStek, LLC and certain of the Sellers (as more fully described below). The Sellers, together with certain of
NEW YORK, NY / ACCESSWIRE / August 13, 2024 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day August Micro-Cap Conference taking place Wednesday and Thursday, August 14-15, 2024. The presentation schedule is subject to change. Please visit www.sidoti.com/events for the most updated version and webinar links. Presentation Schedule*All Times EDTWednesday, August 14, 2024 (Day 1)8:30-9:00*****Alta Global Group (MMA)Mobile-health Network (MNDR)9:15-9:45Steakholder Foods Ltd. (STKH)*****Regenx Tech (RGXTF)10:00-10:30*****Genius Group (GNS)*****10:45-11:15ARC Document Solutions (ARC)Xtract One Technologies (XTRA.TO)C
Sonendo, Inc. ("Sonendo" or the "Company") (OTCQX:SONX), a leading dental technology company and developer of the GentleWave® System, today reported financial results for the second quarter ended June 30, 2024. Recent Highlights Generated $8.3 million total revenue for second quarter of 2024 and carried over a healthy console backlog for the second straight quarter; Drove substantial increases in GAAP gross margin and adjusted gross margins (non-GAAP) to 37.5% and 40.7%, respectively, based primarily on lower manufacturing and console warranty costs; Significantly reduced GAAP operating loss to $6.7 million and adjusted EBITDA (non-GAAP) loss to $5.7 million, a 61% and 55% improv
4 - Sonendo, Inc. (0001407973) (Issuer)
4 - Sonendo, Inc. (0001407973) (Issuer)
4 - Sonendo, Inc. (0001407973) (Issuer)
4 - Sonendo, Inc. (0001407973) (Issuer)
4 - Sonendo, Inc. (0001407973) (Issuer)
4 - Sonendo, Inc. (0001407973) (Issuer)
4 - Sonendo, Inc. (0001407973) (Issuer)
4 - Sonendo, Inc. (0001407973) (Issuer)
4 - Sonendo, Inc. (0001407973) (Issuer)
Sonendo, Inc. ("Sonendo") (OTCQX:SONX), a leading dental technology company and developer of the GentleWave® System, today announced that management will postpone the third quarter 2024 conference call that was previously scheduled for after the market close on Tuesday, November 12th, 2024. The Company still intends to file its audited financial results on November 12th, 2024, but has postponed, until further notice, the accompanying conference call. Management will provide commentary on events subsequent to the end of the quarter ending September 30th, 2024, at a later date. About Sonendo Sonendo is a commercial-stage medical technology Company focused on saving teeth from tooth deca
Sonendo, Inc. ("Sonendo") (OTCQX:SONX), a leading dental technology company and developer of the GentleWave® System, today announced that it will report financial results for the third quarter 2024 after the market close on Tuesday, November 12th, 2024. Management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results. Investors interested in listening to the conference call may do so by dialing (833) 470-1428 for domestic callers or (404) 975-4839 for international callers, using access code: 788725. Live audio of the webcast will be available at: https://investor.sonendo.com. An archived recording will be available on th
Sonendo, Inc. ("Sonendo" or the "Company") (OTCQX:SONX), a leading dental technology company and developer of the GentleWave® System, today reported financial results for the second quarter ended June 30, 2024. Recent Highlights Generated $8.3 million total revenue for second quarter of 2024 and carried over a healthy console backlog for the second straight quarter; Drove substantial increases in GAAP gross margin and adjusted gross margins (non-GAAP) to 37.5% and 40.7%, respectively, based primarily on lower manufacturing and console warranty costs; Significantly reduced GAAP operating loss to $6.7 million and adjusted EBITDA (non-GAAP) loss to $5.7 million, a 61% and 55% improv
Sonendo, Inc. ("Sonendo") (OTCQX:SONX), a leading dental technology company and developer of the GentleWave® System, today announced that it will report financial results for the second quarter 2024 after the market close on Wednesday, August 7th, 2024. Management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results. Investors interested in listening to the conference call may do so by dialing (833) 470-1428 for domestic callers or (404) 975-4839 for international callers, using access code: 699662. Live audio of the webcast will be available at: https://investor.sonendo.com. An archived recording will be available on
Sonendo, Inc. (OTCQX:SONX) ("Sonendo"), a leading dental technology company and developer of the GentleWave® System, today reported financial results for the first quarter ended March 31, 2024 Recent Highlights Recorded total revenue of $7.0 million for first quarter of 2024, exceeding previously issued guidance of $6.0 million; ending the quarter with installed base of 1,142 and achieved a healthy console backlog Increased average procedure instrument selling price from $71.60 in the fourth quarter of 2023 to $75.00 in the first quarter of 2024 by limiting certain discount programs and focusing on utilization opposed to shipments. In the future quarters, we expect procedure instrum
Sonendo, Inc. ("Sonendo") (OTCQX:SONX), a leading dental technology company and developer of the GentleWave® System, today announced that it will report financial results for the first quarter 2024 after the market close on Wednesday, May 8th, 2024. Management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results. Investors interested in listening to the conference call may do so by dialing (833) 470-1428 for domestic callers or (404) 975-4839 for international callers, using access code: 627665. Live audio of the webcast will be available at: https://investor.sonendo.com. An archived recording will be available on the
Sonendo, Inc. (OTCQX:SONX) ("Sonendo" or the "Company"), a leading dental technology company and developer of the GentleWave® System, today reported financial results for the quarter and year ended December 31, 2023. Highlights Total revenue of $43.9 million for the full year 2023, representing growth of 5% over the full year 2022 As of December 31, 2023, the installed base was 1,134 units, representing growth of approximately 16% compared to December 31, 2022 In March 2024, finalized divestiture of our TDO practice management software segment, resulting in gross proceeds of approximately $16.0 million Restructured our Perceptive term loan including a one-time $15.0 million pr
Sonendo, Inc. ("Sonendo") (OTCQX:SONX), a leading dental technology company and developer of the GentleWave® System, today announced that it will report financial results for the fourth quarter and full year 2023 after the market close on Monday, March 11th, 2024. Management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results. Investors interested in listening to the conference call may do so by dialing (833) 470-1428 for domestic callers or (404) 975-4839 for international callers, using access code: 426330. Live audio of the webcast will be available at: https://investor.sonendo.com. An archived recording will be av
Sonendo, Inc. ("Sonendo"), a leading dental technology company and developer of the GentleWave® System, today reported financial results for the third quarter ended September 30, 2023. Recent Highlights Total revenue of $10.4 million for the third quarter of 2023, representing growth of 6%, compared to prior year period Reduced cash burn to approximately $10 million in the third quarter of 2023; additionally, implemented reduction in force in November 2023 to further conserve cash and improve operating efficiency Procedure instrument revenue of $5.1 million for the third quarter of 2023, representing growth of approximately 7% compared to prior year period Ending installed bas
Sonendo, Inc. ("Sonendo") (NYSE:SONX), a leading dental technology company and developer of the GentleWave® System, today announced that it will report financial results for the third quarter 2023 after the market close on Wednesday, November 8th, 2023. Management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results. Investors interested in listening to the conference call may do so by dialing (833) 470-1428 for domestic callers or (404) 975-4839 for international callers, using access code: 878491. Live audio of the webcast will be available at: https://investor.sonendo.com. An archived recording will be available on
John Bostjancic Appointed as Chief Financial Officer Bob Guyatt Appointed as Senior Vice President of Marketing John McGaugh Promoted to Senior Vice President of Operations Sonendo, Inc. (OTCQX:SONX) ("Sonendo"), a leading dental technology company and developer of the GentleWave® System, today announced the appointment of John Bostjancic as Chief Financial Officer, the appointment of Robert Guyatt as Senior Vice President of Marketing, and the promotion of John McGaugh to Senior Vice President of Operations. "Sonendo is embarking on a reset strategy to drive fundamental change within the organization," said Bjarne Bergheim, President and Chief Executive Officer of Sonendo. "We have fil
The Partnership Agreements Aim to Increase the Number of Endodontic Practices Offering the GentleWave System Sonendo, Inc. (NYSE:SONX), a leading dental technology company and developer of the GentleWave® System, today announced the signing of two new strategic partnership agreements with the country's leading endodontic dental service organizations (DSOs) to expand patient access to a best-in-class root canal experience. As a result of these partnerships, the GentleWave System with CleanFlow™ Technology, which offers a less invasive and less painful alternative to traditional root canal therapy, will be available in more endodontic offices nationwide. Sonendo previously announced the a
Sonendo, Inc. (NYSE:SONX), a leading dental technology company and developer of the GentleWave® System, today announced that on September 25, 2023, the Compensation Committee of Sonendo's Board of Directors granted restricted stock unit awards covering an aggregate of 14,000 shares of its common stock to two new, non-executive employees to induce them to join the company. The awards were granted under Sonendo's 2023 Employment Inducement Incentive Award Plan (the "Inducement Plan"), which was adopted on March 2, 2023 and provides for the granting of equity awards to prospective employees of Sonendo under NYSE Listing Rule 303A.08. The restricted stock unit awards vest over a four-year p
Bringing More Than 20 Years of Experience to Sonendo, Lindberg Will Focus on Accelerating Sales Growth Sonendo, Inc. (NYSE:SONX), a leading dental technology company and developer of the GentleWave® System, today announced the appointment of Joanne Lindberg as Vice President of Sales, North America. As Sonendo continues to scale and further establish its leadership position within the endodontic market, Lindberg will oversee sales strategy and execution across the United States and Canada. With a focus on increasing adoption and driving utilization of the GentleWave System, she will serve as a key member of Sonendo's commercial leadership team. "Joanne has a proven track record of scaling
Former Procter & Gamble and current Align executive brings extensive global business acumen in brand-building and consumer product excellence Sonendo, Inc. (NYSE:SONX) ("Sonendo"), a leading dental technology company and developer of the GentleWave® System, today announced the appointment of Raj Pudipeddi as a member of its Board of Directors. Raj currently serves as Chief Product and Marketing Officer, Senior Vice President and Managing Director of the Asia Pacific region for Align Technology, a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics
LAGUNA HILLS, Calif., Nov. 16, 2021 /PRNewswire/ -- Sonendo, Inc., (NYSE: SONX) a leading dental technology company and developer of the GentleWave® System, today announced the appointment of Alma Salazar as its Associate Vice President, Professional and Consumer Marketing. In her role, Salazar will spearhead the company's professional and consumer marketing programs and content, while providing guidance on connecting with prospective patients in a meaningful and compelling way. "We are really excited to have Alma join our commercial leadership team at Sonendo at such a pivot